Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Waled Mohsen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|September 15, 2025
Mesalazine-induced neutropenia: a rare idiosyncratic reactionDeloshaan Subhaharan, Waled Mohsen
ACG Case Reports Journal|June 5, 2024
Leukocytoclastic Vasculitis-Associated Myocarditis as an Extraintestinal Manifestation of Crohn's DiseaseRoney Shibu, Waled Mohsen
Internal Medicine Journal|April 13, 2017
Hepatitis A to E: what's new?Waled Mohsen, Miriam T Levy
Journal of Crohn'S & Colitis|January 3, 2021
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021Vipin Gupta, Waled Mohsen, Thomas P Chapman, et al.
ACG Case Reports Journal|July 6, 2026
Cytotoxic T-Lymphocyte-Associated Protein 4 Deficiency Colitis Masked by Recurrent Cytomegalovirus Colitis Successfully Treated With VedolizumabRoney Shibu, Gabin Soosaipillai, Sooraj Rajendran Pillai, et al.
ACG Case Reports Journal|August 8, 2025
Nivolumab-Induced Refractory Hemorrhagic Gastritis and Duodenitis Requiring Multimodal Biologic TherapyRoney Shibu, Kayla Scully, Waled Mohsen, et al.
Open Heart|November 8, 2023
Inflammatory bowel disease patients have an increased risk of acute coronary syndrome: a systematic review and meta-analysisAmmar Zaka, Naim Mridha, Deloshaan Subhaharan, et al.
World Journal of Gastroenterology|March 29, 2021
Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?Waled Mohsen, Astrid-Jane Williams, Gabrielle Wark, et al.
Internal Medicine Journal|October 8, 2019
Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savingsYang Wu, Brian Lin, Cynthuja Thilakanathan, et al.
World Journal of Gastroenterology|May 14, 2023
Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adultsDeloshaan Subhaharan, Pradeep Kakkadasam Ramaswamy, Laura Willmann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|September 15, 2025
Mesalazine-induced neutropenia: a rare idiosyncratic reactionDeloshaan Subhaharan, Waled Mohsen
ACG Case Reports Journal|June 5, 2024
Leukocytoclastic Vasculitis-Associated Myocarditis as an Extraintestinal Manifestation of Crohn's DiseaseRoney Shibu, Waled Mohsen
Internal Medicine Journal|April 13, 2017
Hepatitis A to E: what's new?Waled Mohsen, Miriam T Levy
Journal of Crohn'S & Colitis|January 3, 2021
Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021Vipin Gupta, Waled Mohsen, Thomas P Chapman, et al.
ACG Case Reports Journal|July 6, 2026
Cytotoxic T-Lymphocyte-Associated Protein 4 Deficiency Colitis Masked by Recurrent Cytomegalovirus Colitis Successfully Treated With VedolizumabRoney Shibu, Gabin Soosaipillai, Sooraj Rajendran Pillai, et al.
ACG Case Reports Journal|August 8, 2025
Nivolumab-Induced Refractory Hemorrhagic Gastritis and Duodenitis Requiring Multimodal Biologic TherapyRoney Shibu, Kayla Scully, Waled Mohsen, et al.
Open Heart|November 8, 2023
Inflammatory bowel disease patients have an increased risk of acute coronary syndrome: a systematic review and meta-analysisAmmar Zaka, Naim Mridha, Deloshaan Subhaharan, et al.
World Journal of Gastroenterology|March 29, 2021
Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?Waled Mohsen, Astrid-Jane Williams, Gabrielle Wark, et al.
Internal Medicine Journal|October 8, 2019
Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savingsYang Wu, Brian Lin, Cynthuja Thilakanathan, et al.
World Journal of Gastroenterology|May 14, 2023
Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adultsDeloshaan Subhaharan, Pradeep Kakkadasam Ramaswamy, Laura Willmann, et al.
Pageof 2